Ageing with HIV

The population of people living with HIV (PLWH) is growing older with an estimated 4 million over the age of 50 years, a figure which has doubled since the introduction of effective antiretroviral therapy (ART) and which is increasing globally. Despite effective ART, PLWH still experience excess morbidity and mortality compared to the general population with increased prevalence of age-related, non-AIDS illnesses (NAI) such as cardiovascular disease, malignancies, cognitive impairment and reduced bone mineral density, which impact disability and everyday functioning. This review will discuss the challenges presented by comorbidities in ageing PLWH and discuss the aetiology and management of age-related illnesses in this vulnerable population.

• Publication year

  2018

• Venue

  Healthcare

• Publication date

  2018-02-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/healthcare6010017PMID 29443936PMCID 5872224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gut microbiota and aging.

  2018cited by this paper
• Cardiovascular Complications of HIV Infection.

  2017cited by this paper
• Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States

  2017cited by this paper
• Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies

  2017cited by this paper
• Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation

  2017cited by this paper
• Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment Week 144 Results

  2017cited by this paper
• Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Patients Older Than 60 Years

  2017cited by this paper
• Associations between cognitive impairment and patient‐reported measures of physical/mental functioning in older people living with HIV

  2017cited by this paper
• Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial.

  2017cited by this paper
• Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection

  2017cited by this paper
• Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

  2017cited by this paper
• Patterns of Cardiovascular Mortality for HIV-Infected Adults in the United States: 1999 to 2013.

  2016cited by this paper
• SIV Infection-Mediated Changes in Gastrointestinal Bacterial Microbiome and Virome Are Associated with Immunodeficiency and Prevented by Vaccination.

  2016cited by this paper
• Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients

  2016cited by this paper
• Trends in Cardiovascular Disease Mortality Among Persons With HIV in New York City, 2001-2012.

  2016cited by this paper
• Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?

  2016cited by this paper
• Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals.

  2016cited by this paper
• Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy

  2016cited by this paper
• The gut microbiome, diet, and links to cardiometabolic and chronic disorders

  2016cited by this paper
• Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?

  2016cited by this paper
• Correlates of Prevalent Disability Among HIV-Infected Elderly Patients

  2016cited by this paper
• A Single-dose Zoledronic Acid Infusion Prevents Antiretroviral Therapy-induced Bone Loss in Treatment-naive HIV-infected Patients: A Phase IIb Trial.

  2016cited by this paper
• HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment

  2016cited by this paper
• Inflammatory Markers Associated With Subclinical Coronary Artery Disease: The Multicenter AIDS Cohort Study

  2016cited by this paper
• Geriatric Assessments and Association With VACS Index Among HIV-Infected Older Adults in San Francisco

  2016cited by this paper
• Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome.

  2016cited by this paper
• Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV‐positive persons

  2016cited by this paper
• Aging and the human gut microbiota—from correlation to causality

  2015cited by this paper
• HIV infection and osteoporosis.

  2015cited by this paper
• Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.

  2015cited by this paper
• Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels.

  2015cited by this paper
• Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection.

  2015cited by this paper
• Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now?

  2015cited by this paper
• HIV Infection, Cardiovascular Disease Risk Factor Profile, and Risk for Acute Myocardial Infarction

  2015cited by this paper
• Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s.

  2015cited by this paper
• Mixed membership trajectory models of cognitive impairment in the multicenter AIDS cohort study

  2015cited by this paper
• The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV‐1 infection

  2015influential reference
• Gut microbiota and aging

  2015cited by this paper
• 2013 American College of Cardiology/American Heart Association and 2004 Adult Treatment Panel III cholesterol guidelines applied to HIV-infected patients with/without subclinical high-risk coronary plaque

  2014cited by this paper
• Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort

  2014cited by this paper
• Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men.

  2014cited by this paper
• Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks

  2014cited by this paper
• Relative contribution of HIV infection, demographics and body mass index to bone mineral density

  2014cited by this paper
• Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges

  2014cited by this paper
• HLA Alleles Association with Changes in Bone Mineral Density in HIV-1-Infected Adults Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine

  2014cited by this paper
• Bone Mineral Density Over 96 Weeks in Adults Failing First-Line Therapy Randomized to Raltegravir/Lopinavir/Ritonavir Compared With Standard Second-Line Therapy

  2014cited by this paper
• A Compositional Look at the Human Gastrointestinal Microbiome and Immune Activation Parameters in HIV Infected Subjects

  2014cited by this paper
• Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation

  2014cited by this paper
• Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline

  2014cited by this paper
• Increasing trends in HIV prevalence among people aged 50 years and older: evidence from estimates and survey data

  2014cited by this paper
• HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality

  2014cited by this paper
• Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study).

  2014cited by this paper
• Frailty in people aging with human immunodeficiency virus (HIV) infection.

  2014cited by this paper
• HIV Infection and Its Association With an Excess Risk of Clinical Fractures: A Nationwide Case–Control Study

  2014cited by this paper
• Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.

  2014cited by this paper
• Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers

  2013cited by this paper
• Incident fractures in HIV-infected individuals: a systematic review and meta-analysis

  2013cited by this paper
• The end of AIDS: HIV infection as a chronic disease.

  2013cited by this paper
• HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: A population‐based cohort study

  2013cited by this paper
• Impact of switching from zidovudine to tenofovir disoproxil fumarate on bone mineral density and markers of bone metabolism in virologically suppressed HIV-1 infected patients; a substudy of the PREPARE study.

  2013cited by this paper
• Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia

  2013cited by this paper
• Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death.

  2013cited by this paper
• Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men

  2013cited by this paper
• Frailty in HIV-Infected Adults in South Africa

  2013cited by this paper
• Supplemental materials for: Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

  2013cited by this paper
• Non-AIDS-defining Cancers Among HIV-Infected Patients

  2013cited by this paper
• Antiretroviral Therapy Protects against Frailty in HIV-1 Infection

  2013cited by this paper
• Serum Levels of Cytokines and Biomarkers for Inflammation and Immune Activation, and HIV-Associated Non-Hodgkin B-Cell Lymphoma Risk

  2013cited by this paper
• HIV infection and the risk of acute myocardial infarction.

  2013cited by this paper
• Therapeutic Options for Low Bone Mineral Density in HIV-Infected Subjects

  2012cited by this paper
• Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons

  2012cited by this paper
• Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta‐analysis

  2012cited by this paper
• Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals

  2012cited by this paper
• Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV.

  2012cited by this paper
• No Association of Abacavir Use With Myocardial Infarction: Findings of an FDA Meta-Analysis

  2012cited by this paper
• Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine

  2012cited by this paper
• Synergistic Effects of HIV Infection and Older Age on Daily Functioning

  2012cited by this paper
• Antiretroviral neurotoxicity

  2012cited by this paper
• Risk Factors for Falls in HIV-Infected Persons

  2012cited by this paper
• Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome.

  2012cited by this paper
• Arterial inflammation in patients with HIV.

  2012cited by this paper
• Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.

  2011cited by this paper
• Association Between HIV Infection, Antiretroviral Therapy, and Risk of Acute Myocardial Infarction: A Cohort and Nested Case–Control Study Using Québec's Public Health Insurance Database

  2011cited by this paper
• HIV infection and bone disease: implications for an aging population.

  2011cited by this paper
• Premature age-related comorbidities among HIV-infected persons compared with the general population.

  2011cited by this paper
• CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy

  2011cited by this paper
• Stable bone density in HAART-treated individuals with HIV: a meta-analysis.

  2011cited by this paper
• A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study)

  2011cited by this paper
• HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons

  2011cited by this paper
• Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study *

  2011cited by this paper
• A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men.

  2011cited by this paper
• A review of premature frailty in HIV-infected persons; another manifestation of HIV-related accelerated aging.

  2011cited by this paper
• The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?

  2011cited by this paper
• Characterization of HIV-Associated Neurocognitive Disorders Among Individuals Starting Antiretroviral Therapy in South Africa

  2010cited by this paper
• A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206

  2010cited by this paper
• Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

  2010cited by this paper
• Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection

  2010cited by this paper
• Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.

  2010cited by this paper
• Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study

  2010cited by this paper
• Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.

  2010cited by this paper

• Kidney disease screening at ART initiation among adults with HIV in Uganda: A missed priority for a high-risk population

  2026cites this paper
• Cardiovascular risk factors and cardiac dysfunction in people with HIV and breast cancer: an observational cohort study in Botswana

  2026influential citation
• Hypertension among people living with HIV receiving dolutegravir-based antiretroviral therapy in ethiopia: a cross-sectional study

  2025cites this paper
• Correlates of the sexual and reproductive health service utilization among older people living with HIV in China: Findings from the sexual well-being (SWELL) Study.

  2025cites this paper
• Aging and HIV: Recent Findings in Contributing Factors

  2025influential citation
• Non-Communicable Diseases in Patients with Human Immunodeficiency Virus and Their Risk Factors

  2025cites this paper
• Prevalence and determinants of HIV testing among adults aged 50 years and older in China: A population-based study

  2025cites this paper
• Understanding stigma as a barrier to cancer prevention and treatment: a qualitative study among people living with HIV in Uganda and Zambia

  2025cites this paper
• A United States HIV provider survey of antiretroviral therapy management in people living with HIV with co-occurring conditions

  2025cites this paper
• Limited restoration of T cell subset distribution and immune function in older people living with HIV-1 receiving HAART

  2025influential citation
• Introducing the WHO ICOPE approach into HIV care: A perspective on healthy ageing in people living with HIV

  2025cites this paper
• “It’s not just HIV anymore”: A qualitative exploration of health, research, community and mental health priorities of long-term survivors of HIV in the United States

  2025cites this paper
• HIV/AIDS knowledge and stigma attitudes among older men in Sichuan Province, Southwest China: a cross-sectional study

  2025cites this paper
• Interventions to reduce HIV-related stigma among older people living with HIV in sub-Saharan Africa: a scoping review

  2025cites this paper
• Kidney disease screening among adults with HIV in Uganda: a missed priority for a high-risk population

  2025cites this paper
• TAXA DE DETECÇÃO DE HIV E FATORES ASSOCIADOS EM IDOSOS DE 2010 A 2022 EM PONTA GROSSA

  2025cites this paper
• Limited Availability of Dental Services in Resource-limited Settings for People Living With HIV/AIDS (PLWHA)

  2025cites this paper
• Frailty among community-dwelling people living with HIV: a scoping review protocol

  2025cites this paper
• Patterns of sleep problems and associated factors in older people living with HIV: A latent class analysis

  2025cites this paper
• Trends in prevalence of anaemia among people living with HIV in the UK: 20 cross‐sectional analyses using population‐based electronic primary healthcare records

  2025cites this paper
• B cells and atherosclerosis: A HIV perspective

  2024influential citation
• Beyond identity and generations: bringing life course theory to studies of older gay men

  2024cites this paper
• HIV-Associated Cardiovascular Disease Pathogenesis: An Emerging Understanding Through Imaging and Immunology.

  2024cites this paper
• One-Year Frailty Transitions Among Persons With HIV Aged 70 Years or Older on Antiretroviral Treatment

  2024cites this paper
• Combining molecular transmission network analysis and spatial epidemiology to reveal HIV-1 transmission pattern among the older people in Nanjing, China

  2024cites this paper
• Network analysis to prioritize issues for intervention to improve the health‐related quality of life of people with HIV in Spain

  2024cites this paper
• Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine: 48-Week Results from the SALSA Study

  2024cites this paper
• Kidney Impairment in HIV/AIDS Patients Attending Kabutare Level II Teaching Hospital, Southern Province of Rwanda

  2024cites this paper
• Co-Creation of Patient-Centered Metrics for Long-Term Well-Being Involving People with HIV and HIV Care Providers

  2024cites this paper
• Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies

  2024cites this paper
• Evolution of HIV/AIDS Prevention and Control Policies in China: A Grounded Theory Approach

  2024cites this paper
• Association Between TyG Index, Liver Steatosis and Immunosenescence in People Living with HIV

  2024cites this paper
• Patient reported experiences in older adults living with HIV – a scoping review

  2024cites this paper
• Impact of switching to a dolutegravir‐based regimen on body weight changes: insights from West African adult HIV cohorts

  2024cites this paper
• Prevent with Pleasure: A systematic review of HIV public communication campaigns incorporating a pleasure-based approach

  2024cites this paper
• Care, Vital Nostalgia, and the Archive: Notes on Viral Cultures: Activist Archiving in the Age of AIDS

  2023cites this paper
• Hypertension and Cardiovascular Disease Risk Among Individuals With Versus Without HIV

  2023cites this paper
• The challenge of dealing with non-AIDS comorbidities for people living with HIV: Perspectives and experiences of patients and healthcare providers

  2023cites this paper
• Multiplex Analysis of Cytokines and Chemokines in Persons Aging With or Without HIV

  2023cites this paper
• Ageing People Living with HIV/AIDS, PLWHA; More Dental Challenges; the Romanian Dental Professional’s Point of View

  2023cites this paper
• Correlates of Sexual Lifestyles Among Older Adults Living With HIV in China: Findings From the Sexual Well-being (SWELL) Study

  2023cites this paper
• HIV-1–Host Interaction in Gut-Associated Lymphoid Tissue (GALT): Effects on Local Environment and Comorbidities

  2023cites this paper
• Non-communicable disease comorbidities in HIV patients: diabetes, hypertension, heart disease, and obstructive sleep apnea as a neglected issue

  2023cites this paper
• How is Aging Perceived to Affect Well-being in Women Older than 50 Years Living With HIV? A Qualitative Systematic Review

  2023cites this paper
• Current Scenario and Strategies to Tackle Cardiovascular Disease Risk in HIV Geriatrics

  2023cites this paper
• Research priorities in HIV, aging and rehabilitation: building on a framework with the Canada-International HIV and Rehabilitation Research Collaborative

  2023cites this paper
• [Utilization of sexual and reproductive health services and its correlates among community- based older adults in Chongqing].

  2023cites this paper
• Aging with HIV: Increased Risk of HIV Comorbidities in Older Adults

  2022cites this paper
• Factors associated with verbal fluency in older adults living with HIV in West Africa: A longitudinal study

  2022cites this paper
• Prevalence and Vulnerability Factors Associated with HIV and Syphilis in Older People from Subnormal Agglomerate, Brazilian Amazon

  2022cites this paper
• Association between HIV duration and symptom distress among middle-aged and elderly people with HIV-infected in China: a cross-sectional study

  2022cites this paper
• Epidemiological profile of PLWH aged 50 and over at the Ahala district medical center, Yaounde

  2022cites this paper
• The renal-bone axis in older people living with HIV on stable antiretroviral therapy: A sub-analysis of the GS-US-104-0423 study

  2022cites this paper
• Weight gain during the dolutegravir transition in the African Cohort Study

  2022cites this paper
• A comparative analysis on characteristics and mortalities of four key transmission populations on antiretroviral therapy: a retrospective cohort study in Northwest China

  2022cites this paper
• Independent Risk Factors for Deaths due to AIDS in Chongqing, China: Does Age Matter?

  2021cites this paper
• Лекарственная совместимость в лечении хронических инфекционных болезней

  2021cites this paper
• Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV

  2021influential citation
• Trajectories of and Disparities in HIV Prevalence among Black, White, and Hispanic/Latino High Risk Heterosexuals in 89 U.S. Metropolitan Statistical Areas, 1992-2013.

  2021cites this paper
• Incidence of cardiometabolic diseases in a Lesotho HIV cohort: Evidence for policy decision-making

  2021cites this paper
• Mini-review: Elucidating the psychological, physical, and sex-based interactions between HIV infection and stress

  2021cites this paper
• Monitoring of older HIV‐1‐positive adults by HIV clinics in the United Kingdom: a national quality improvement initiative

  2020cites this paper
• A review of potential microbiome-gut-brain axis mediated neurocognitive conditions in persons living with HIV

  2020cites this paper
• Falls in people living with HIV: a scoping review

  2020cites this paper
• Bone density, microarchitecture and tissue quality after 1 year of treatment with dolutegravir/abacavir/lamivudine.

  2020cites this paper
• Déterminants du vieillissement dans l'infection par le VIH : étude SIMBAD

  2019cites this paper
• Drug–drug interactions of a two-drug regimen of dolutegravir and lamivudine for HIV treatment

  2019cites this paper
• Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine

  2018cites this paper
• Extending the concept of successful ageing to persons ageing with disabilities

  2018cites this paper
• The immune profile in HIV: A useful signature in future HIV research?

  2018cites this paper
• Ageing, Diversity and Equality: Social Justice Perspectives (Open Access)

  2017cites this paper